Also listed on Optiscan Biomedical Corporation, an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Jan 28, 2030 · High confidence
20-year base term ends Sep 14, 2029
Sep 14, 2009
Jan 28, 2030
Apr 5, 2016
This patent's term runs 136 days past its 20-year base term on prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Sep 14, 2009, when application 12/559,328, the earliest non-provisional in its chain, was filed (this one was filed Apr 5, 2013) | Sep 14, 2029 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +136 days, USPTO patent term adjustment record | Jan 28, 2030 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,417,311) | resolves to Jan 28, 2030, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jan 28, 2030 | High confidence |
This family
| US 8,470,241 | In force Feb 2032 | Feb 2032 |
| US 8,412,293 | In force Aug 2031 | Aug 2031 |
| Application 12/247,956 | Abandoned not computed | not computed |
| US 7,972,296 | In force Oct 2028 | Oct 2028 |
| Application 12/251,339 | Abandoned not computed | not computed |
| Application 12/251,357 | Abandoned not computed | not computed |
| Application 12/546,568 | Abandoned not computed | not computed |
| US 8,417,311 | In force Jun 2030 | Jun 2030 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jan 7, 2016 Reel 37429, frame 528 | Rule, Peter | Optiscan Biomedical Corporation | Assignment of Assignor's Interest |
| Feb 28, 2018 Reel 45469, frame 948 | Optiscan Biomedical Corporation | East West Bank | Amended and Restated IP Security Agreement |
| Feb 9, 2021 Reel 55201, frame 812 | East West Bank | Insulet Corporation | Assignment of Assignor's Interest |
| May 4, 2021 Reel 56135, frame 974 | Insulet Corporation | Morgan Stanley Senior Funding, Inc., as Collateral Agent | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 8,417,311, ends no earlier than this term, so it caps nothing.